MEMark I. Evans

Mark I. Evans

*This is an algorithmically generated author record based on publicly available information.

Mark I. Evans has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Demographic Factors for Utilization of Invasive Genetic Testing after Multifetal Pregnancy Reduction

    by Carol L. Baker, Baruch Feldman, Alex G. Shalhoub, Melissa A. Ayoub, Eric L. Krivchenia, Yuval Yaron, Mark I. Evans

    Objective: Pregnant infertility patients are commonly old enough to be offered prenatal diagnosis. However, they may be reluctant to undergo an additional invasive procedure. We, therefore, sought to determine what demographic factors, including race and ethnic group, influenced patients’ decisions to undergo genetic testing in addition to multifetal pregnancy reduction (MFPR). Methods: We retrospectively reviewed MFPR patients from July 1997 to June 1999 at our institution. Invasive genetic testing was routinely discussed. Maternal age, race, ethnicity, religion, egg source for in vitro fertilization (IVF) patients, and the remaining fetuses following MFPR were analyzed for invasive genetic testing determinants and were compared to our experiences with genetic referents to us for singleton pregnancies. 132 consecutive patients, of whom 49 were ≧35 years, including 15 having IVF with donor eggs, were included. Results: Maternal age was the single most significant determinant of testing. In donor egg cases, donor age was significant. Ethnic background, previous children, and the remaining number of fetuses after MFPR were also significant determinants. Conclusion: MFPR patients share similar demographics to the advanced maternal age population. Despite the very stressful situations, our data suggest that maternal age, and therefore genetic risk, is the most important determinant of choosing whether or not to have testing. However, patients’ decisions are, to varying degrees, modified by religious and ethnic considerations.


  • Maternal Weight Correction for α-Fetoprotein: Mathematical Truncations Revisited

    by Mark I. Evans, Harold Harrison, Joseph E. O'BRien, Xiaohua Huang, Frank A. Chervenak, George P. Henry, Ronald J. Wapner

    The objective of this study was to determine if maternal weight correction as implemented 20 years ago for alpha-fetoprotein (AFP) testing is still appropriate, and what should be the weight cutoff for correction. AFP measurements from 44,951 biochemical screening cases from a single laboratory were divided by maternal weight, and separated into high >/=2.5 multiples of the median (MOM), and low /= 2.5 MOM). Using a truncated range to 200 lbs. (for women greater than 200), produces more uniform results than using an upper cutoff of 250 for truncation (2.7% vs 5.0% >/= 2.5 MOM). The same relationship is seen for "lows." Without correction, higher weight lowers AFP, correction to 250 lbs. overcompensates, and 200 lbs. gives the most even distribution, and, therefore, optimizes the distribution of highs.


  • Principles of Screening

    by Mark I. Evans, Eric L. Krivchenia, Ronald J. Wapner, Richard Iii Depp